Global Intracranial Stenosis Stents Market Size study & Forecast, by Product (Self-expanding Stents, Embolization Coil Support Intracranial Stents, Venous Sinus Stents, Balloon-expanding & Other Stents), by End User (Hospitals, Ambulatory Surgical Centers

Global Intracranial Stenosis Stents Market Size study & Forecast, by Product (Self-expanding Stents, Embolization Coil Support Intracranial Stents, Venous Sinus Stents, Balloon-expanding & Other Stents), by End User (Hospitals, Ambulatory Surgical Centers, Others) and Regional Analysis, 2023-2030

Global Intracranial Stenosis Stents Market is valued at approximately USD 0.79 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period 2023-2030. The Intracranial Stenosis Stents Market refers to the global market for medical devices designed to treat intracranial arterial stenosis, a condition characterized by the narrowing of blood vessels in the brain, by providing structural support and improving blood flow. These stents are specifically designed for use in the intracranial arteries and play a crucial role in the management of cerebrovascular diseases, such as ischemic stroke, by reducing the risk of recurrent strokes and improving patient outcomes. The Intracranial Stenosis Stents Market is being driven by factors such as the rising prevalence of intracranial disease and increasing preference for minimally invasive procedures.

Intracranial stenosis stents are medical devices used to treat narrowing or blockage of the blood vessels within the brain. Intracranial stenosis refers to the condition where the arteries supplying blood to the brain become narrowed or restricted due to the buildup of plaque or atherosclerosis. This can lead to reduced blood flow and an increased risk of stroke. According to a 2022 report by the World Stroke Organization, the global incidence of new stroke cases exceeds 12.2 million each year. According to same source among different age groups, stroke has the highest prevalence among individuals aged 70 years and older, accounting for 67% of cases. The second-highest prevalence is observed among individuals between the ages of 15 and 49, comprising 22% of cases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. As elder population are more concerned about hypertension and stroke. Thus, the increasing number of aging population fueling the growth of the market. In addition, the rising incidence of stroke and the continuous growing aging population create lucrative opportunities for the market. However, the lack of skilled professionals may hinder the growth of the market throughout the forecast period of 2023-2030.

The key regions considered for the Global Intracranial Stenosis Stents Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high incidence rate of hypertension & stroke and the presence of well-established healthcare facilities and rising prevalence of intracranial stenosis cases. Asia Pacific is considered the fastest growing region during the forecasted period due to the growing aging population and negative lifestyle choices & stress and rising incidence of ischemic stroke.

Major market player included in this report are:
Phenox GmbH
Medtronic
Acandis GmbH
MicroPort Scientific Corporation
MicroVention, Inc.
CERENOVUS (Johnson & Johnson)
Sino Medical Sciences Technology, Inc.
Stryker corporation
Boston Scientific Corporation
Abbott Laboratories

Recent Developments in the Market:
On August 2022, MicroPort NeuroTech™ made its independent debut at WLNC, a prestigious event in the field of neurointervention, garnering the attention of renowned experts. These experts had the opportunity to explore the brain vascular disease solutions exhibited at MicroPort NeuroTech™'s booth. Dr. Eduardo Wairich, who performed the first implantation of the NUMEN™ coil in Brazil, also visited the booth and shared his experiences with the staff, expressing his recognition of MicroPort NeuroTech™ products and his anticipation for the upcoming launch of the U-track™ intracranial support catheter system in Brazil. Notably, Minimally Invasive Brain Science™ has successfully completed the first implantation of the NUMEN™ coil and the APOLLO™ intracranial arterial stent system in Brazil, thanks to the collaboration of esteemed Brazilian neurointervention teams.

Global Intracranial Stenosis Stents Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, End User, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Self-expanding Stents
Embolization Coil Support Intracranial Stents
Venous Sinus Stents
Balloon-expanding & Other Stents

By End User:
Hospitals
Ambulatory Surgical Centers
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned
Phenox GmbH
Medtronic
Acandis GmbH
MicroPort Scientific Corporation
MicroVention, Inc.
CERENOVUS (Johnson & Johnson)
Sino Medical Sciences Technology, Inc.
Stryker corporation
Boston Scientific Corporation
Abbott Laboratories

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.